378 related articles for article (PubMed ID: 26379788)
1. Casein-Coated Fe5C2 Nanoparticles with Superior r2 Relaxivity for Liver-Specific Magnetic Resonance Imaging.
Cowger TA; Tang W; Zhen Z; Hu K; Rink DE; Todd TJ; Wang GD; Zhang W; Chen H; Xie J
Theranostics; 2015; 5(11):1225-32. PubMed ID: 26379788
[TBL] [Abstract][Full Text] [Related]
2. Highly magnetic iron carbide nanoparticles as effective T(2) contrast agents.
Huang G; Hu J; Zhang H; Zhou Z; Chi X; Gao J
Nanoscale; 2014 Jan; 6(2):726-30. PubMed ID: 24287667
[TBL] [Abstract][Full Text] [Related]
3. In vivo risk evaluation of carbon-coated iron carbide nanoparticles based on short- and long-term exposure scenarios.
Herrmann IK; Beck-Schimmer B; Schumacher CM; Gschwind S; Kaech A; Ziegler U; Clavien PA; Günther D; Stark WJ; Graf R; Schlegel AA
Nanomedicine (Lond); 2016 Apr; 11(7):783-96. PubMed ID: 26979124
[TBL] [Abstract][Full Text] [Related]
4. Casein-coated iron oxide nanoparticles for high MRI contrast enhancement and efficient cell targeting.
Huang J; Wang L; Lin R; Wang AY; Yang L; Kuang M; Qian W; Mao H
ACS Appl Mater Interfaces; 2013 Jun; 5(11):4632-9. PubMed ID: 23633522
[TBL] [Abstract][Full Text] [Related]
5. Fe5C2 nanoparticles with high MRI contrast enhancement for tumor imaging.
Tang W; Zhen Z; Yang C; Wang L; Cowger T; Chen H; Todd T; Hekmatyar K; Zhao Q; Hou Y; Xie J
Small; 2014 Apr; 10(7):1245-9. PubMed ID: 24352976
[TBL] [Abstract][Full Text] [Related]
6. Gold-coated iron oxide nanoparticles as a T2 contrast agent in magnetic resonance imaging.
Ahmad T; Bae H; Rhee I; Chang Y; Jin SU; Hong S
J Nanosci Nanotechnol; 2012 Jul; 12(7):5132-7. PubMed ID: 22966533
[TBL] [Abstract][Full Text] [Related]
7. Citrate coated iron oxide nanoparticles with enhanced relaxivity for in vivo magnetic resonance imaging of liver fibrosis.
Saraswathy A; Nazeer SS; Jeevan M; Nimi N; Arumugam S; Harikrishnan VS; Varma PR; Jayasree RS
Colloids Surf B Biointerfaces; 2014 May; 117():216-24. PubMed ID: 24646453
[TBL] [Abstract][Full Text] [Related]
8. Biocompatible Peptide-Coated Ultrasmall Superparamagnetic Iron Oxide Nanoparticles for In Vivo Contrast-Enhanced Magnetic Resonance Imaging.
Chee HL; Gan CRR; Ng M; Low L; Fernig DG; Bhakoo KK; Paramelle D
ACS Nano; 2018 Jul; 12(7):6480-6491. PubMed ID: 29979569
[TBL] [Abstract][Full Text] [Related]
9. Magnetic Reactive Oxygen Species Nanoreactor for Switchable Magnetic Resonance Imaging Guided Cancer Therapy Based on pH-Sensitive Fe
Yu J; Zhao F; Gao W; Yang X; Ju Y; Zhao L; Guo W; Xie J; Liang XJ; Tao X; Li J; Ying Y; Li W; Zheng J; Qiao L; Xiong S; Mou X; Che S; Hou Y
ACS Nano; 2019 Sep; 13(9):10002-10014. PubMed ID: 31433945
[TBL] [Abstract][Full Text] [Related]
10. Increased transverse relaxivity in ultrasmall superparamagnetic iron oxide nanoparticles used as MRI contrast agent for biomedical imaging.
Mishra SK; Kumar BS; Khushu S; Tripathi RP; Gangenahalli G
Contrast Media Mol Imaging; 2016 Sep; 11(5):350-361. PubMed ID: 27230705
[TBL] [Abstract][Full Text] [Related]
11. One pot synthesis of water-dispersible dehydroascorbic acid coated Fe3O4 nanoparticles under atmospheric air: blood cell compatibility and enhanced magnetic resonance imaging.
Gupta H; Paul P; Kumar N; Baxi S; Das DP
J Colloid Interface Sci; 2014 Sep; 430():221-8. PubMed ID: 24956575
[TBL] [Abstract][Full Text] [Related]
12. Antibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imaging.
Lee H; Lee E; Kim DK; Jang NK; Jeong YY; Jon S
J Am Chem Soc; 2006 Jun; 128(22):7383-9. PubMed ID: 16734494
[TBL] [Abstract][Full Text] [Related]
13. Polyethyleneimine-mediated synthesis of superparamagnetic iron oxide nanoparticles with enhanced sensitivity in T2 magnetic resonance imaging.
Do MA; Yoon GJ; Yeum JH; Han M; Chang Y; Choi JH
Colloids Surf B Biointerfaces; 2014 Oct; 122():752-759. PubMed ID: 25194592
[TBL] [Abstract][Full Text] [Related]
14. Short-chain PEG molecules strongly bound to magnetic nanoparticle for MRI long circulating agents.
Ruiz A; Salas G; Calero M; Hernández Y; Villanueva A; Herranz F; Veintemillas-Verdaguer S; Martínez E; Barber DF; Morales MP
Acta Biomater; 2013 May; 9(5):6421-30. PubMed ID: 23321305
[TBL] [Abstract][Full Text] [Related]
15. Magnetic PEGylated Pt3Co nanoparticles as a novel MR contrast agent: in vivo MR imaging and long-term toxicity study.
Yin S; Li Z; Cheng L; Wang C; Liu Y; Chen Q; Gong H; Guo L; Li Y; Liu Z
Nanoscale; 2013 Dec; 5(24):12464-73. PubMed ID: 24165858
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of the L-peptide modified magnetic lipid nanoparticles as targeted magnetic resonance imaging contrast agent for the nasopharyngeal cancer.
Chen YC; Min CN; Wu HC; Lin CT; Hsieh WY
J Biomater Appl; 2013 Nov; 28(4):580-94. PubMed ID: 23174955
[TBL] [Abstract][Full Text] [Related]
17. Diblock-copolymer-mediated self-assembly of protein-stabilized iron oxide nanoparticle clusters for magnetic resonance imaging.
Tähkä S; Laiho A; Kostiainen MA
Chemistry; 2014 Mar; 20(10):2718-22. PubMed ID: 24523066
[TBL] [Abstract][Full Text] [Related]
18. Co-precipitation of DEAE-dextran coated SPIONs: how synthesis conditions affect particle properties, stem cell labelling and MR contrast.
Barrow M; Taylor A; García Carrión J; Mandal P; Park BK; Poptani H; Murray P; Rosseinsky MJ; Adams DJ
Contrast Media Mol Imaging; 2016 Sep; 11(5):362-370. PubMed ID: 27358113
[TBL] [Abstract][Full Text] [Related]
19. One-pot facile synthesis of PEGylated superparamagnetic iron oxide nanoparticles for MRI contrast enhancement.
Dai L; Liu Y; Wang Z; Guo F; Shi D; Zhang B
Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():161-7. PubMed ID: 24907749
[TBL] [Abstract][Full Text] [Related]
20. Quantitative Activity Measurements of Brown Adipose Tissue at 7 T Magnetic Resonance Imaging After Application of Triglyceride-Rich Lipoprotein 59Fe-Superparamagnetic Iron Oxide Nanoparticle: Intravenous Versus Intraperitoneal Approach.
Jung CS; Heine M; Freund B; Reimer R; Koziolek EJ; Kaul MG; Kording F; Schumacher U; Weller H; Nielsen P; Adam G; Heeren J; Ittrich H
Invest Radiol; 2016 Mar; 51(3):194-202. PubMed ID: 26674208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
